A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.
Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...
The world’s largest food and beverage company said it plans to launch a frozen food brand that will cater to consumers who ...
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...
Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...
Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...
Lilly officials said 31% of people taking Zepbound lost at least 25% of their body weight compared to 16% of study ...
Novo says that it has regulatory clearance to buy three key manufacturing sites used to make drugs like Wegovy, its ...